Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sirius Real Estate to acquire Southampton business park

(Sharecast News) - Property investor Sirius Real Estate said on Wednesday that it has exchanged contracts to acquire a Southampton business park for £40.5m. Sirius Real Estate said it was continuing to deploy the proceeds of its approximately £152.0m capital raise in July 2024, having exchanged contracts to acquire an established business park with further development opportunities in Southampton.

The FTSE 250-listed firm has agreed to acquire Chalcroft Business Park for £36.5m, representing a net initial yield of 5.5%, as well as an adjoining 4.5-acre piece of development land with outline planning permission for £4.0m.

Sirius added that the 56-acre site also includes a 1.2-acre solar farm, benefiting from a 2013 government Feed-in Tariff expiring in 2038, which produces a third of the estate's power requirements and will support the company's sustainability targets.

The freehold asset is 80% occupied and currently produces a net operating income of £2.1m, with a WAULT of four years to break, while the vacant units should add a further £500,000 to the rent roll once let.

As of 1120 GMT, Sirius shares were up 0.55% at 82.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.